|
The patient was taken to the hospital on (b)(6) 2026 due to swelling in the lower extremity and concerns of infection.Antibiotics were prescribed the week prior after a follow up appointment with the implanting clinician.As of (b)(6) 2026, the patient completed their antibiotics, they are doing well, and resumed using the neurostimulator without issue.
|
|
The other adverse events issues issue questionnaire was reviewed for causes of the reported issue.Based on this review, implanting the device off-label, implanting the device too close to the targeted nerve, and inadvertently puncturing bone or tissue during the procedure have been ruled out.Additionally, the patient having pneumonia and dehydration have been ruled out.A curonix representative conducted a review of sterilization and packaging records for the respective product lot; curonix has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.The stimulator is used to treat pain.The cause of the swelling is unknown.The investigation findings do not lead to a clear conclusion about the cause of the reported issue.Therefore, conclusion has been selected as unable to determine root cause.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in other adverse events issues.Other adverse events issues rates remain acceptably low; thus, a capa is not required.Other adverse events issues rates will continue to be tracked and trended.
|